Thermo Fisher Scientific currently trades with a PEG ratio of 3.86, based on Jun 22, 2026 data. Dividing the 25.47 PE ratio by the 6.6% earnings growth rate produces this figure. Relative to the 3.75 average from the past 4 quarters, the PEG ratio rose by 3.1%.
Historically, Thermo Fisher Scientific maintains a PEG ratio averaging 4.93 across the last ten years. At 3.86, today's PEG ratio sits 22% lower than its historical average. The ten years high came in the Mar 2024 quarter at 26.53, reflecting peak valuation relative to growth. The bottom was reached in the Jul 2021 quarter at 0.18, suggesting favorable value relative to growth during that period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 4.53 | 32.61 | 7.2% |
| 2024 | 4.61 | 31.38 | 6.8% |
| 2023 | N/A | 34.2 | -12.6% |
| 2022 | N/A | 31.02 | -9.5% |
| 2021 | 1.55 | 34.01 | 21.9% |
| 2020 | 0.39 | 28.95 | 74.1% |
| 2019 | 1.33 | 35.16 | 26.4% |
| 2018 | 1.03 | 30.61 | 29.6% |
| 2017 | 3.3 | 33.67 | 10.2% |
| 2016 | 8.61 | 27.56 | 3.2% |
| 2015 | 6.81 | 28.6 | 4.2% |
| 2014 | 0.76 | 26.32 | 34.8% |
| 2013 | 3.5 | 31.54 | 9% |
| 2012 | N/A | 19.69 | -7.2% |
| 2011 | 0.36 | 12.89 | 35.8% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 3.94 | 25.98 | 6.6% |
| Dec 2025 | 4.53 | 32.61 | 7.2% |
| Sep 2025 | 3.19 | 26.77 | 8.4% |
| Jun 2025 | 3.32 | 23.57 | 7.1% |
| Mar 2025 | 3.18 | 29.27 | 9.2% |
| Dec 2024 | 4.61 | 31.38 | 6.8% |
| Sep 2024 | 9.15 | 38.43 | 4.2% |
| Jun 2024 | 3.45 | 34.2 | 9.9% |
| Mar 2024 | 26.53 | 37.14 | 1.4% |
| Dec 2023 | N/A | 34.2 | -12.6% |
| Sep 2023 | N/A | 33 | -14.5% |
| Jul 2023 | N/A | 35.44 | -22.3% |
| Apr 2023 | N/A | 37.33 | -20.2% |
| Dec 2022 | N/A | 31.02 | -9.5% |
| Oct 2022 | N/A | 28.27 | -17.4% |
Measured against past performance, TMO's PEG ratio comes in under the 3, 5 and 10-year averages.
Thermo Fisher Scientific's PEG of 3.86 is higher than the Healthcare sector, the industry and its peers average.
TMO carries a PEG ratio higher than that of peer stocks GE and ISRG. With a PEG ratio of 3.86, Thermo Fisher Scientific sits higher than the 1.4 peer average.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| BIO Bio-Rad Laboratories Inc | 0.45 | $7.52B |
| A Agilent Technologies Inc | 1.1 | $35.72B |
| GE General Electric Co | 1.66 | $370.51B |
| ISRG Intuitive Surgical Inc | 2.37 | $142.71B |
| TMO Thermo Fisher Scientific Inc | 3.86 | $172.44B |
| BDX Becton Dickinson & Co | N/A | $38.77B |
| WAT Waters Corp | N/A | $35.18B |
| TFX Teleflex Inc | N/A | $5.39B |
| BAX Baxter International Inc | N/A | $10.15B |
| DHR Danaher Corp | N/A | $126.12B |
| BRKR Bruker Corp | N/A | $8.61B |
TMO's Jun 22, 2026 PEG ratio comes in at 3.86.
Across the past 3 years, TMO's PEG ratio has centered around 6.88.
Across the past 5 years, TMO's PEG ratio has centered around 5.33.
In the last ten years, TMO's peak PEG ratio of 26.53 occurred in the Mar 2024 quarter.
Compared to the 10-year average, TMO's PEG ratio sits 22% lower.
Slow earnings growth combined with a rich valuation drives TMO's PEG ratio to 3.86.
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jun 22, 2026, Thermo Fisher Scientific carries a PE ratio of 25.47. Earnings grew at 6.6% over the TTM period ending Mar 2026. Applying the formula, this yields a PEG ratio of 3.86. PEG RATIO(3.86) = PE RATIO(25.47) / EPS GROWTH(6.6%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.